A Duke University School of Medicine team reimagines a sci-fi classic as real-world biotech that can speed up biological research.

New strategy could change how we design drugs—especially the large and polar ones that were once too big to work.

An epic collaboration between neuroscientists at Duke and six other institutions has yielded an AI tool that paves the way for new approaches to treating neurological disorders.

Researchers propose a "treatable fetal findings list" that identifies genetic conditions that can be detected with prenatal testing and treated in utero or in the first week of life.

Sabrina Lewandowski was diagnosed with a usually fatal form of glioblastoma that many centers would have considered untreatable. But the research-intensive team at Duke took a different approach — and 23 years later, she's living her life and raising her 13-year-old daughter.

When Hurricane Helene hit Western North Carolina, it left more than flood damage—it fostered mold and fungal growth. Now, a Duke University team is studying how post-disaster fungi could affect health and recovery in a warming world.

The discovery in the lab of Duke cancer pharmacologist Donald McDonnell of a new drug treatment has changed the lives of thousands of patients of a type of breast cancer. The decade-long research behind the drug is exemplary of the benefits of the historical partnership between the federal government and universities in supporting biomedical research. It also shows the singular role universities play in developing treatments that can be brought to market.

Dean Emerita Wilson’s gift will fund an international visiting professorship and Duke’s Center for Nursing Research, to be renamed in her honor.

Duke University start-up company VQ Biomedical is developing a minimally-invasive catheter-based oxygenator for patients whose heart or lungs are failing.

A proposed cap on National Institutes of Health funding could cost Duke University millions and stall critical breakthroughs -- like Laurie Sanders's blood test for early Parkinson's disease.